Search Results - "Kabunda, J."
-
1
10 Oral: AKY-1189, a novel, first-in-class miniprotein radiopharmaceutical designed to deliver Actinium-225 (225Ac) to Nectin-4 expressing tumors with broad therapeutic applications in metastatic urothelial carcinoma (mUC) and other Nectin-4 expressing tumors
Published in European journal of cancer (1990) (01-10-2024)Get full text
Journal Article -
2
-
3
Predictors of Non-Adherence to Public Health Instructions During the COVID-19 Pandemic in the Democratic Republic of the Congo
Published in Journal of multidisciplinary healthcare (01-01-2020)“…Adherence to public health instructions for the COVID-19 is important for controlling the transmission and the pandemic's health and economic impacts. The aim…”
Get full text
Journal Article